| Literature DB >> 35202169 |
Lian-Qun Wang1,2, Kun-Tan Wu1, Ping Yang1, Fang Hou2, Shahid Ali Rajput3, De-Sheng Qi1, Shuai Wang1.
Abstract
Fusarium graminearum is a harmful pathogen causing head blight in cereals such as wheat and barley, and thymol has been proven to inhibit the growth of many pathogens. This study aims to explore the fungistatic effect of thymol on F. graminearum and its mechanism. Different concentrations of thymol were used to treat F. graminearum. The results showed that the EC50 concentration of thymol against F. graminearum was 40 μg/mL. Compared with the control group, 40 μg/mL of thymol reduced the production of Deoxynivalenol (DON) and 3-Ac-DON by 70.1% and 78.2%, respectively. Our results indicate that thymol can effectively inhibit the growth and toxin production of F. graminearum and cause an extensive transcriptome response. Transcriptome identified 16,727 non-redundant unigenes and 1653 unigenes that COG did not annotate. The correlation coefficients between samples were all >0.941. When FC was 2.0 times, a total of 3230 differential unigenes were identified, of which 1223 were up-regulated, and 2007 were down-regulated. Through the transcriptome, we confirmed that the expression of many genes involved in F. graminearum growth and synthesis of DON and other secondary metabolites were also changed. The gluconeogenesis/glycolysis pathway may be a potential and important way for thymol to affect the growth of F. graminearum hyphae and the production of DON simultaneously.Entities:
Keywords: Fusarium graminearum; deoxynivalenol; gluconeogenesis/glycolysis; mycelial growth; thymol; toxin production
Mesh:
Substances:
Year: 2022 PMID: 35202169 PMCID: PMC8877954 DOI: 10.3390/toxins14020142
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1The effect of thymol on the growth of F. graminearum hyphae. (A) Control group; (B) 5 μg/mL thymol treatment group; (C) 10 μg/mL thymol treatment group; (D) 20 μg/mL thymol treatment group; (E) 40 μg/mL thymol treatment group; (F) 80 μg/mL thymol treatment group; (G) 160 μg/mL thymol treatment group.
Figure 2Thymol inhibits the growth of F. graminearum and DON synthesis. (A) Effect of different concentrations of thymol on the mycelial diameter; (B) Inhibition rate of different concentrations of thymol on the growth of F. graminearum; (C) The effect of thymol on the synthesis of DON and 3-Ac-DON at 40 μg/mL (EC50) or 139 μg/mL(EC90) concentrations. a,b Columns with different lowercase letters indicated significant differences between the compared groups (p < 0.05).
Figure 3Function annotation analysis. (A–C) GO function annotation analysis; (D) COG function annotation analysis. Red markers represent annotations related to energy metabolism processes.
Figure 4Analysis of the relationship between samples. (A) PCA analysis between samples; (B) Percentage of up-regulated/down-regulated unigenes identified by different multiples of difference; (C) Heat map of correlation analysis between samples; (D) Distribution of expression levels. CK is the control group, and Treat is the thymol treatment group.
Figure 5Functional enrichment analysis (A) GO function enrichment analysis; (B) KEGG function enrichment analysis.
Unigenes related to mycelial growth.
| Name | COG_ID | FC | Swiss-Prot_Description | Functional Categories |
|---|---|---|---|---|
| CND2 | COG5229 | 2.37 | Condensin complex subunit 2 | Chromatin structure and dynamics |
| MPIP | COG5105 | 3.05 | M-phase inducer phosphatase | Cell cycle control, cell division, chromosome partitioning |
| HSK1 | ENOG410YKCM | 3.25 | Cell cycle serine/threonine-protein kinase hsk1 | |
| CDC45 | ENOG410XR8E | 2.00 | Cell division control protein 45 homolog | |
| APC10 | COG5156 | 3.50 | Anaphase-promoting complex subunit 10 | |
| CALM | COG5126 | 2.98 | Calmodulin | |
| HXT2 | ENOG410XNQK | 0.46 | High-affinity glucose transporter HXT2 | Carbohydrate transport and metabolism |
| PHSG | COG0058 | 2.41 | Glycogen phosphorylase | |
| HSP80 | COG0326 | 0.06 | Heat shock cognate protein 80 | Coenzyme transport and metabolism |
| FSR4 | ENOG4111F9D | 2.44 | Trans-enoyl reductase fsr4 | Lipid transport and metabolism |
| PARP2 | ENOG410XP18 | 13.54 | ADP-ribose polymerase 2 | Translation, ribosomal structure, and biogenesis |
| SMC2 | COG1196 | 2.79 | Structural maintenance of chromosomes protein 2 | Transcription |
| SAK1 | ENOG410XSHE | 2.00 | Protein sak1 | |
| MCM1 | COG5068 | 2.02 | Transcription factor of morphogenesis MCM1 | |
| ORC4 | ENOG410XSK0 | 2.70 | Origin recognition complex subunit 4 | Replication, recombination, and repair |
| RAD1 | ENOG410YHQU | 2.26 | DNA damage checkpoint control protein rad1 | |
| SKP1 | COG5201 | 2.42 | E3 ubiquitin ligase complex SCF subunit scon-3 | Posttranslational modification, protein turnover |
| CDK1 | ENOG410XPP3 | 2.26 | Cyclin-dependent kinase 1 | Signal transduction mechanisms |
| PPZ | COG0639 | 0.49 | Serine/threonine-protein phosphatase PP-Z | |
| PHLN | COG3511 | 0.08 | Non-hemolytic phospholipase C | Cell wall/membrane/envelope biogenesis |
| GAL10 | COG1087 | 3.03 | Bifunctional protein GAL10 |
Unigenes related to the synthesis of DON.
| Name | COG_ID | FC | Swiss-Prot_Description | Functional Categories |
|---|---|---|---|---|
| TRI4 | COG2124 | 0.01 | Cytochrome P450 monooxygenase | Cytochrome P450 |
| TRI13 | COG2124 | 0.02 | Cytochrome P450 monooxygenase | |
| TRI11 | COG2124 | 0.02 | Trichothecene C-15 hydroxylase | |
| TRI1 | COG2124 | 0.01 | Cytochrome P450 monooxygenase | |
| TRI8 | ENOG410YF7H | 0.01 | Trichothecene C-3 esterase | Trichothecene C-3 esterase |
| TRI6 | ENOG410YRUA | 0.01 | Trichothecene biosynthesis transcription regulator 6 | Trichothecene biosynthesis transcription regulator |
| TRI5 | ENOG410YBAU | 0.01 | Trichodiene synthase | Trichodiene synthase |
| CLM1 | ENOG410YEIS | 0.01 | Longiborneol synthase CLM1 | |
| TRI3 | ENOG4112AIP | 0.01 | Trichothecene 15-O-acetyltransferase | Trichothecene 15-O-acetyltransferase |
| TRI14 | ENOG41118DK | 0.03 | Core trichothecene cluster | Core trichothecene cluster |
| TR101 | ENOG410YJA8 | 0.09 | Trichothecene 3-O-acetyltransferase | Transferase family |
| TRI10 | ENOG410YFZP | 0.06 | Trichothecene biosynthesis transcription regulator 10 | Fungal trichothecene efflux pump |
| TRI12 | ENOG410XNQK | 0.01 | Trichothecene efflux pump TRI12 | |
| ACLA | ENOG410XNQK | 0.01 | MFS efflux transporter aclA | |
| STR3 | ENOG41109Q9 | 0.06 | Siderophore iron transporter 3 | |
| LACP | ENOG410XNQK | 0.08 | Lactose permease | |
| NAG3 | COG0477 | 0.00 | Major facilitator superfamily multidrug transporter NAG3 | |
| GSFJ | ENOG410XNQK | 0.08 | Probable efflux pump gsfJ | |
| YJ94 | ENOG410ZNSM | 0.00 | Uncharacterized membrane protein | |
| MF227 | ENOG4111EZJ | 0.02 | Probable efflux pump mfs2 | |
| ATB_A | COG0477 | 0.07 | Efflux pump atB | |
| FUS6 | ENOG410XNQK | 0.06 | Efflux pump FUS6 | |
| FUB11 | COG0477 | 0.06 | Efflux pump FUBT | |
| MIRB | ENOG410XNQK | 0.01 | Siderophore iron transporter mirB | |
| ROQT | ENOG410XNQK | 0.03 | Efflux pump roqT | |
| SIT1 | ENOG410ZYHG | 0.15 | Siderophore iron transporter 1 |